Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
13vPnC vs 23vPS in Adults
NCT00427895Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2007
- Primary completion
- Aug 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Prevnar 13 in pneumococcal infection, sponsored by Pfizer. Started Feb 2007; status: completed.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00427895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00427895.